Dr. Flavio De Rosa

Associate Partner at Widler & Schiemann AG

Over 30 years of professional experience in the pharmaceutical and CRO industry, serving in progressively senior positions across all aspects of clinical research and drug development. Flavio has worked in medium and large pharmaceutical companies, including over 20 years at F. Hoffmann-La Roche. He has also worked at a specialized CRO, supporting small and medium sized Pharma companies and Biotech startups.
  • Provided scientific expertise covering drug development activities from initial study design and concept to final study report writing and submission activities in diverse therapeutic areas.
  • Formulated drug development strategies with reference to applicable local and international regulations, scientific and clinical study requirements, Good Clinical Practice and regulatory affairs for new oncology compounds.
  • Supplied drug development expertise and support to Biotechs, including representation as “expert witness” to Angel Fund investors.
  • Created and led task forces, steering committees and DSMB/DMCs in diverse therapeutic indications.
  • Evaluated candidate molecules from Biotech and other start-up companies for either inclusion into a portfolio or for development collaborations.

Download Vita as PDF
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /